PICKERING, ONTARIO--(CCNMatthews - March 6, 2006) - Sergio Martines, President and CEO of NSP Pharma Corp. ("NSP")(TSX VENTURE:NSP) is pleased to announce that Naturale Science Pharma Inc.("NSPI"), NSP's wholly owned subsidiary, has signed a Letter of Intent ("LOI") with Jiangsu Longliqi Group Co. Ltd. ("Longliqi") based in Jiangsu, People's Republic of China. The LOI specifies that NSPI and Longliqi will form a joint venture which will co-develop a business plan for the distribution of NSPI's products throughout the Greater China market. NSPI will control a majority interest in the joint venture company.

Established in 1986, Longliqi is a large and well-known enterprise in China with over 260 branches. Its major consumer business is in the cosmetics industry (branded products and OEM), and the Company has the distinction of being the leading domestic player in China's cosmetics and toiletries market. Longliqi's estimated sales exceed RMB $3 billion (approximately C$425 million) on an annual basis.

China is now considered one of the largest and fastest growing markets within the global beauty industry, with total consumer spending in this sector exceeding US$5 billion in 2005. According to a recent national government research project, spending on beauty products and services has been increasing at an average of 15 - 20% annually over the last 5 years. The study also forecasts that growth will continue at a rate of 25% per annum over the next 5 years.

"This endeavour will introduce NSPI's offerings to the world's largest population," stated president Sergio Martines. "Beauty and skin care products are in heavy demand by China's enormous consumer base, and there is a trend for that demand to increase substantially in the years ahead. We are very excited to pursue the opportunity and will work avidly toward gaining a profitable share of this immense and rapidly growing market."